Mr. Johnson’s base salary increased to $1.4 million last year, up about 8.4 percent from the year prior, according to a recent Securities and Exchange Commission filing. He received less incentive compensation and stock awards in 2016 than in the year prior. Mr. Johnson earned total compensation of $21.3 million last year, up from $17.8 million in 2015.
Mr. Rutherford’s base salary increased to $793,750 in 2016, up from $714,570 in 2015. However, after factoring in higher stock awards and lower incentive compensation, Mr. Rutherford’s total compensation dipped slightly to $4.09 million, down from $4.16 million in the year prior.
HCA, which includes 169 hospitals, ended 2016 with net income of $2.89 billion on $41.49 billion in revenue. That’s an improvement from 2015 when the company recorded net income of $2.13 billion on revenues of $39.68 billion.
More articles on compensation issues:
10 findings on CFO compensation
Healthcare CEOs dominate WSJ’s list of highest paid employees at nonprofits
No pay raises for top CHS executives in 2017
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
